£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

US Anti-Inflammatory Scleroderma Drug Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 24 days · 24 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 03 August 2026 08 August 2026 14 August 2026 20 August 2026 26 August 2026
View at Amazon ↗

Price data last checked 67 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 24 days • 1 price levels

Days at Price
24 days 0 6 12 18 24 £520 Days at Price

Price Analysis

Most common price: £520 (24 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 24 days

Description

This comprehensive study provides an in-depth analysis of the latent demand for anti-inflammatory scleroderma drugs across the United States from 2023 to 2028. By evaluating potential industry earnings (P.I.E.) in millions of U.S. dollars, this report offers a granular view of market opportunities. Data is provided for approximately 12,600 cities, allowing for precise regional assessments. Users can access specific percent share data for each city relative to its state and the nation as a whole. These comparative benchmarks enable professionals to evaluate city-level performance against broader markets. This statistical approach supports data-driven decision-making for distribution planning and sales force strategy development.

Key Features

Provides latent demand outlooks for anti-inflammatory scleroderma drugs in the United States for the 2023-2028 period.

Estimates potential industry earnings (P.I.E.) in millions of U.S. dollars across 12,600 cities.

Includes city-level percent share data compared to both state and national totals for quick benchmarking.

Supports effective distribution and sales force strategies through detailed statistical analysis of US cities and states.

Published by ICON Group International, Inc. to assist in market demand forecasting.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in India
99% match

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in India

£515.00 02 Sep 2026
The 2026-2031 World Outlook for Anti-Inflammatory Scleroderma Drugs
99% match

The 2026-2031 World Outlook for Anti-Inflammatory Scleroderma Drugs

£885.00 28 Oct 2026
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in China
99% match

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in China

£495.00 01 Nov 2026
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in Japan
99% match

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in Japan

£495.00 19 Aug 2026
The 2023 Report on Anti-Inflammatory Scleroderma Drugs: World Market Segmentation by City
99% match

The 2023 Report on Anti-Inflammatory Scleroderma Drugs: World Market Segmentation by City

£795.00 25 Aug 2026
The 2025-2030 World Outlook for Anti-Inflammatory Scleroderma Drugs
98% match

The 2025-2030 World Outlook for Anti-Inflammatory Scleroderma Drugs

Price unavailable
US Anti-Inflammatory Scleroderma Drug Outlook 2023-2028
98% match

US Anti-Inflammatory Scleroderma Drug Outlook 2023-2028

£490.00 21 Aug 2026
The 2023-2028 Outlook for Scleroderma Diagnostics and Therapeutics in China
98% match

The 2023-2028 Outlook for Scleroderma Diagnostics and Therapeutics in China

£495.00 26 Sep 2026
The 2023-2028 Outlook for Physician-Dispensed Skin Care Cosmeceuticals in the United States
97% match

The 2023-2028 Outlook for Physician-Dispensed Skin Care Cosmeceuticals in the United States

£520.00 21 Aug 2026
The 2023-2028 Outlook for Psoriatic Arthritis Treatments in the United States
97% match

The 2023-2028 Outlook for Psoriatic Arthritis Treatments in the United States

£520.00 03 Oct 2026
The 2023-2028 Outlook for Medicated Skin Care Products in India
97% match

The 2023-2028 Outlook for Medicated Skin Care Products in India

£515.00 20 Aug 2026
The 2023-2028 Outlook for Skin Care in India
97% match

The 2023-2028 Outlook for Skin Care in India

£515.00 16 Aug 2026
The 2023-2028 Outlook for Physician-Dispensed Skin Care Cosmeceuticals in India
97% match

The 2023-2028 Outlook for Physician-Dispensed Skin Care Cosmeceuticals in India

£515.00 21 Aug 2026
The 2023-2028 Outlook for Skin Care Cosmeceuticals in the United States
97% match

The 2023-2028 Outlook for Skin Care Cosmeceuticals in the United States

£520.00 22 Aug 2026
The 2023 Report on Psoriasis Medicines: World Market Segmentation by City
97% match

The 2023 Report on Psoriasis Medicines: World Market Segmentation by City

£795.00 01 Oct 2026
The 2023-2028 Outlook for Skin Care Products in India
97% match

The 2023-2028 Outlook for Skin Care Products in India

£515.00 28 Oct 2026
The 2016-2021 Outlook for Medicated Skin Care in Greater China
97% match

The 2016-2021 Outlook for Medicated Skin Care in Greater China

£595.00 03 Sep 2026
The 2016-2021 Outlook for Medicated Skin Care in Japan
97% match

The 2016-2021 Outlook for Medicated Skin Care in Japan

£595.00 25 Aug 2026
The 2023-2028 Outlook for Mass-Market Skin Care Products in India
97% match

The 2023-2028 Outlook for Mass-Market Skin Care Products in India

£515.00 28 Aug 2026
The 2023-2028 World Outlook for Systemic Psoriasis Therapeutics
97% match

The 2023-2028 World Outlook for Systemic Psoriasis Therapeutics

£795.00 02 Sep 2026
The 2023-2028 Outlook for Skin Care Cosmeceuticals in India
97% match

The 2023-2028 Outlook for Skin Care Cosmeceuticals in India

£515.00 24 Aug 2026
The 2023-2028 Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs in the United States
97% match

The 2023-2028 Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs in the United States

£520.00 28 Aug 2026
The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in India
97% match

The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in India

£515.00 25 Aug 2026
The 2023-2028 Outlook for Men's Skin Care Products in India
97% match

The 2023-2028 Outlook for Men's Skin Care Products in India

£515.00 25 Aug 2026